RESUMO
Vitiligo is characterized by skin depigmentation, which can lead to profound psychological effects and decreased quality of life, especially for those with skin of color. Individuals with vitiligo may utilize complementary and alternative medicine (CAM) due to limited treatment options with varying efficacy.An anonymous, multiple-choice, cross-sectional questionnaire was distributed to participants with vitiligo in the United States through online forums. Data on disease characteristics, use of prescription medications, use of topical therapies, supplements, and diets, and perceptions of CAM were collected.In total, 625 respondents completed the survey. Overall, 32.5% of participants (203/625) have tried CAM. Commonly reported CAM include supplements of vitamin D (57.7%, 116/203), vitamin B12 (46.3%, 93/203), vitamin C (27.4%, 55/203), topical Nigella sativa oil (26.4%, 53/203), oral omega-3 fatty acids (24.9%, 50/203), folic acid (22.9%, 46/203), and vitamin E (22.9%, 46/203). Frequently cited reasons for CAM use include desire to try "new" (40.4%, 82/203) or "more natural" (26.6%, 54/203) therapies, "frustration with conventional medicine" (24.6%, 50/203), and fear of "adverse side effects of conventional medicine" (23.6%, 48/203). Non-White participants were more likely than their White counterparts to report CAM use and have more positive perceptions of CAM therapies. Less than half (43.3%, 88/203) of CAM users reported that they disclosed their use of CAM with their physician.Dermatologists should be mindful of CAM and ask patients about their use. Further investigation of the role of CAM as adjuvant therapy for vitiligo is warranted to better advise patients.
Assuntos
Terapias Complementares , Suplementos Nutricionais , Vitiligo , Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Terapias Complementares/estatística & dados numéricos , Terapias Complementares/métodos , Estudos Transversais , Suplementos Nutricionais/estatística & dados numéricos , Qualidade de Vida , Pigmentação da Pele , Inquéritos e Questionários/estatística & dados numéricos , Estados Unidos , Vitiligo/terapia , Vitiligo/psicologia , Minorias Étnicas e RaciaisRESUMO
Vitiligo is a depigmenting skin disease that can carry significant psychosocial impact. Health care providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this contribution, we review the psychosocial aspects of vitiligo management, including the debate over the "disease-ification" of vitiligo, its effects on quality of life and mental health, and methods to holistically assist affected individuals beyond just treatment of the vitiligo itself.
Assuntos
Vitiligo , Humanos , Vitiligo/terapia , Vitiligo/psicologia , Qualidade de Vida/psicologiaRESUMO
Background and Objectives: Vitiligo is a skin disorder characterized by hypopigmented macules occurring due to melanocyte destruction. An interplay of several biochemical mechanisms has been proposed to explain the etiopathogenesis of vitiligo, such as genetic, autoimmune responses, generation of inflammatory mediators, oxidative stress, and melanocyte detachment mechanisms. There is no cure for vitiligo; however, pharmacological treatment measures (cosmetic camouflage creams, steroids, psoralen and ultraviolet A (PUVA) therapy, narrowband UVB) are available, but they could have certain side effects. We reported an interesting case of vitiligo in Saudi Arabia that showed reversal of vitiligo, which is an extremely rare phenomenon, with the objective of probing the probable reasons for this reversal. To the best of our knowledge, there is no study on vitiligo that has reported spontaneous reversal of vitiligo in Saudi Arabia so far. Materials and Method: The patient presented to the Family Medicine clinic with a history of restoration of melanin pigment in his lesions after 3 years of the onset of vitiligo. Patients history was taken carefully along with clinical examination, carried out necessary biomedical lab investigations and compiled the data. The data at the time of pigment restoration were compared to the previous data when he developed the lesions. Result: The probable reasons for vitiligo reversal could be markedly decreased psychological stress, regular consumption of an antioxidant-rich herbal drink made of curcumin and honey, and dietary switchover to vegetarianism and an alcohol-free lifestyle. Conclusions: Curcumin-based herbal remedies could be an alternative option to treat vitiligo. These methods must be further explored through clinical trials as they are safer, easily available, and more affordable.
Assuntos
Curcumina , Vitiligo , Masculino , Humanos , Vitiligo/tratamento farmacológico , Vitiligo/psicologia , Arábia Saudita , Curcumina/uso terapêutico , Terapia PUVA/métodos , Esteroides/uso terapêuticoAssuntos
COVID-19/prevenção & controle , Fototerapia , Vitiligo/psicologia , Vitiligo/terapia , Adolescente , Adulto , Ansiedade/etiologia , Depressão/etiologia , Progressão da Doença , Utilização de Instalações e Serviços/estatística & dados numéricos , Feminino , Acessibilidade aos Serviços de Saúde , Humanos , Internet , Masculino , Cooperação do Paciente/estatística & dados numéricos , Medidas de Resultados Relatados pelo Paciente , Fototerapia/estatística & dados numéricos , Recidiva , SARS-CoV-2 , Autocuidado/estatística & dados numéricos , Estresse Psicológico/etiologia , Inquéritos e Questionários , Telemedicina/estatística & dados numéricos , Adulto JovemRESUMO
Vitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients. Treatment of vitiligo aims to prevent the spread of disease and facilitate repigmentation of affected lesions. The mainstay of treatment for unstable vitiligo has been topical agents (corticosteroids, calcineurin inhibitors) and phototherapy. However, systemic treatments are increasingly being shown to have a significant impact on the course of the disease as monotherapy or adjunctive therapy. Of note, oral mini-pulsed corticosteroid therapy, methotrexate, minocycline, ciclosporin, Janus kinase inhibitors and certain supplements have been used in the systemic treatment of vitiligo. We review the underlying evidence supporting the use of each of these systemic treatments.
Assuntos
Corticosteroides/uso terapêutico , Inibidores de Calcineurina/uso terapêutico , Terapia Neoadjuvante/métodos , Fototerapia/métodos , Vitiligo/patologia , Vitiligo/terapia , Administração Oral , Administração Tópica , Corticosteroides/administração & dosagem , Corticosteroides/efeitos adversos , Antibacterianos/administração & dosagem , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Inibidores de Calcineurina/administração & dosagem , Inibidores de Calcineurina/efeitos adversos , Terapia Combinada , Ciclosporina/administração & dosagem , Ciclosporina/efeitos adversos , Ciclosporina/uso terapêutico , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/efeitos adversos , Fármacos Dermatológicos/uso terapêutico , Humanos , Inibidores de Janus Quinases/administração & dosagem , Inibidores de Janus Quinases/efeitos adversos , Inibidores de Janus Quinases/uso terapêutico , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Metotrexato/uso terapêutico , Minociclina/administração & dosagem , Minociclina/efeitos adversos , Minociclina/uso terapêutico , Avaliação de Resultados em Cuidados de Saúde , Fototerapia/efeitos adversos , Psicologia , Vitiligo/psicologia , alfa-MSH/administração & dosagem , alfa-MSH/efeitos adversos , alfa-MSH/análogos & derivados , alfa-MSH/uso terapêuticoRESUMO
INTRODUCTION: The use of complementary and alternative medicine (CAM) in dermatology has been increasing in recent years. Patterns of CAM use by vitiligo patients have not previously been assessed in Saudi Arabia. Therefore, it is worth exploring the perceptions, knowledge, and attitudes of Saudi vitiligo patients toward CAM. METHODS: A cross-sectional study was conducted for 12 months among Saudi vitiligo patients at King Abdulaziz Medical City in Riyadh. A validated self-administered questionnaire, comprised of four sections, was used to collect the data. Descriptive analysis was used, and a chi-squared test was used to determine the association between dependent and independent variables. RESULTS: Two hundred patients with vitiligo were enrolled, 56% of whom were female. The average age was 31.6 ± 15.45 years. Approximately 52% of the patients were either current or previous users of CAM. Among the patients, 44.5% had been asked by their dermatologist about their CAM use, and 18.5% preferred not to disclose their CAM use. Social media was the most common source of information for CAM (28%). CONCLUSION: More than half of the vitiligo patients in our study used some form of CAM. The most popular remedies were honey (37%), Nigella sativa (29%), and olive oil (29%).
Assuntos
Terapias Complementares/psicologia , Terapias Complementares/estatística & dados numéricos , Conhecimentos, Atitudes e Prática em Saúde , Vitiligo/terapia , Adolescente , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Qualidade de Vida , Arábia Saudita , Vitiligo/psicologia , Adulto JovemRESUMO
INTRODUCTION: Vitiligo is a common chronic depigmentation disease. Patients are generally advised to protect themselves from the sun. METHODS: One hundred fifty-three patients diagnosed with vitiligo and 106 healthy volunteers with no additional dermatological disease were included in the study. We evaluated the sun-protection habits of patients with vitiligo and controls, and also assessed their knowledge and attitudes toward sun exposure. RESULTS: Rates of sunscreen use, high-factor sunscreen use, and remaining in the shade were significantly higher among patients (p = 0.004, p = 0.028, p = 0.040). We found significantly higher rates of modifying vacation habits, high sun-protection factors (SPF) sunscreen use, and preferring to remain in the shade among patients using phototherapy (p = 0.016, p = 0.019, p = 0.028). We showed higher rates of modification of vacation habits, wearing sunglasses, and remaining in the shade among patients with longer disease durations (p = 0.026, p = 0.001, and p = 0.017). CONCLUSIONS: We determined higher rates of sunscreen use, high-SPF sunscreen use, and tendencies to remain in the shade in vitiligo patients compared to the general population. We also determined that disease duration and treatment with phototherapy alters sun-protection habits, but the presence of generalized disease and lesions in visible areas such as the face does not alter patients' habits.
Assuntos
Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Queimadura Solar/prevenção & controle , Protetores Solares/administração & dosagem , Vitiligo/psicologia , Adolescente , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
Vitiligo is a common acquired depigmenting skin disease characterized by a progressive loss of functional melanocytes. It may appear from the first years of life to late adulthood. Childhood vitiligo (CV), defined as vitiligo that begins before the age of 12 years, is common and may differ from post-CV in terms of epidemiology, clinical presentation, comorbidities, and treatment options. Taking into consideration the potential significant psychosocial impact of the disease on both children and their parents, all available therapeutic options must be offered to patients who desire treatment. According to the most recent guidelines, topical corticosteroids, topical calcineurin inhibitors, and narrowband ultraviolet B phototherapy are the most commonly used treatment modalities for vitiligo in children. This review presents recent data regarding the whole spectrum of CV. Differences between CV and post-CV are also discussed.
Assuntos
Doenças Autoimunes do Sistema Nervoso/epidemiologia , Fármacos Dermatológicos/administração & dosagem , Estresse Psicológico/etiologia , Terapia Ultravioleta/métodos , Vitiligo/terapia , Administração Tópica , Idade de Início , Inibidores de Calcineurina/administração & dosagem , Criança , Comportamento Infantil/psicologia , Comorbidade , Glucocorticoides/administração & dosagem , Humanos , Pais/psicologia , Prevalência , Qualidade de Vida , Estresse Psicológico/psicologia , Resultado do Tratamento , Vitiligo/epidemiologia , Vitiligo/psicologiaRESUMO
Hypopigmentation and depigmentation of the skin can be due to multiple causes and has a broad differential diagnosis. The most common cause of depigmentation worldwide is vitiligo. This disorder affects 1-2% of the world's population and is seen in all races. Vitiligo is an autoimmune disorder in which the predominant cause is an attack by CD8+ cytotoxic T cells on melanocytes in the epidermis. This condition can have a significant negative impact on the quality of life of affected individuals. Treatment options currently include psychological counseling, topical therapy, systemic therapy, phototherapy, surgical therapy, and depigmentation. In patients with stable, refractory disease, successful repigmentation has been achieved using mini-punch grafting, blister grafting, and non-cultured epidermal suspension (NCES) grafting. Emerging therapies include the Janus kinase (JAK) inhibitors ruxolitinib and tofacitinib. Further studies exploring the pathogenesis of vitiligo are warranted in order to optimize treatment for affected patients. J Drugs Dermatol. 2019;18(3 Suppl):s115-116.
Assuntos
Doenças Autoimunes/terapia , Qualidade de Vida , Vitiligo/terapia , Administração Cutânea , Administração Oral , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/imunologia , Doenças Autoimunes/psicologia , Linfócitos T CD8-Positivos/efeitos dos fármacos , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/metabolismo , Aconselhamento/métodos , Fármacos Dermatológicos/uso terapêutico , Diagnóstico Diferencial , Epiderme/transplante , Humanos , Janus Quinases/antagonistas & inibidores , Janus Quinases/imunologia , Melanócitos/transplante , Micose Fungoide/diagnóstico , Nitrilas , Fototerapia/métodos , Piperidinas/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Pirazóis/uso terapêutico , Pirimidinas/uso terapêutico , Pirróis/uso terapêutico , Pigmentação da Pele/efeitos dos fármacos , Pigmentação da Pele/imunologia , Tinha Versicolor/diagnóstico , Vitiligo/diagnóstico , Vitiligo/imunologia , Vitiligo/psicologiaRESUMO
BACKGROUND: Psychological interventions are recommended as part of routine management of vitiligo. However, the development and effectiveness of such interventions have been rarely addressed. This study aimed to identify key components for a psychological intervention for people with vitiligo. This is the first time perspectives of people with vitiligo, and healthcare professionals (HCPs) have been directly explored to inform intervention content and delivery. OBJECTIVES: To identify 1. which psychological difficulties are highlighted that can be targeted by an intervention; 2. what is important in terms of intervention content and delivery. METHODS: Web-based questionnaires containing both quantitative and qualitative items were completed by people with vitiligo and HCPs. Questionnaires collected data from people with vitiligo on demographics, clinical features, psychological difficulties and priority areas for psychological interventions, including ideas on delivery and content. HCPs questionnaires collected data on psychological difficulties reported, use of psychological interventions and suitability within health services. Quantitative data were analysed using descriptive statistics, and qualitative data utilized thematic framework analysis. RESULTS: A total of 100 people with vitiligo (66% female, 92% Caucasian) and 39 HCPs (54% dermatologists) participated. Key areas of difficulty were the impact of vitiligo, coping, issues with appearance/body image and the sun, and medical interactions. Vitiligo on sensitive sites was associated with more psychological impact. Interventions directed at increasing acceptance, confidence and self-esteem, as well as managing embarrassment, were important. These issues could be managed through interventions such as cognitive behavioural therapy, mindfulness and acceptance and commitment therapy. Both people with vitiligo and HCPs favoured individual interventions. CONCLUSION: Vitiligo has significant impact, requiring ongoing psychosocial support. There is a strong need for a psychoeducational intervention with focus on acceptance and managing social impact. The results of this study are the first steps to informing the development of a patient-centred psychological intervention.
Assuntos
Terapia de Aceitação e Compromisso , Adaptação Psicológica , Atenção Plena , Vitiligo/psicologia , Vitiligo/terapia , Atitude do Pessoal de Saúde , Imagem Corporal/psicologia , Constrangimento , Feminino , Humanos , Internet , Masculino , Pesquisa Qualitativa , Autoeficácia , Luz Solar/efeitos adversos , Inquéritos e Questionários , Reino UnidoRESUMO
Vitiligo is an acquired depigmentation disorder of the skin. Patients with vitiligo often face a challenging disease course, having to cope with a condition that is known to be physically disfiguring, psychologically devastating, and socially stigmatizing. Although an extensive amount of research has been directed towards the dermatologic treatment of vitiligo, an overall lack of data exists investigating treatment of the psychological and emotional burden of patients with vitiligo. This paper reviews the literature for treatment options in patients with vitiligo that specifically target the psychosocial domain. Despite being limited in quantity, several studies have proven the benefits of adjuvant care in the form of group therapy, cognitive behavioral therapy, and self-help programs. Although preliminary evidence is promising, larger prospective studies are needed to further define the role of these psychosocial interventions before integrating them in a more official capacity into the standard of care for patients with vitiligo. Because of the considerable impact of vitiligo beyond its physical symptoms, dermatologists ought to consider the utility of adjuvant therapies to adequately address impairments in self-esteem, body image, and quality of life in patients with vitiligo. J Drugs Dermatol. 2018;17(6):688-691.
Assuntos
Sistemas de Apoio Psicossocial , Psicoterapia/métodos , Autoimagem , Vitiligo/psicologia , Vitiligo/terapia , Terapia Combinada/métodos , Terapia Combinada/psicologia , Fármacos Dermatológicos/administração & dosagem , Humanos , Qualidade de Vida/psicologia , Resultado do Tratamento , Vitiligo/diagnósticoRESUMO
Vitiligo is a chronic disorder of depigmentation that has different treatment modalities, but patients' nonadherence is common. This study aimed to assess the influence of patients' medication beliefs on patients' adherence to topical, oral medications, and phototherapy in vitiligo. Between September 2015 and February 2016, 260 patients with vitiligo were asked to fill in the Beliefs about Medicines Questionnaire (BMQ) to assess their beliefs about therapy for vitiligo. Their adherence to the therapy was examined using the 8-item Morisky Medication Adherence Scale (MMAS-8). RESULTS: The MMAS-8 scale and BMQ had good internal consistency (Cronbach's α = 0.78 and 0.66, respectively). Using Morisky's recommended cutoff point, 71% of patients were categorized as low or nonadherent to the scheduled therapy. Patients who perceived specific necessity of dermatological medicines significantly adhered to their therapy (OR 1.23; 95% CI 1.09, 1.38; p = 0.001) whereas patients who had specific concerns about the adverse effects exhibited significant low adherence (OR 0.65; 95% CI 0.56, 0.76; p < 0.001). CONCLUSION: Positive beliefs about the necessity of medications in vitiligo do not necessarily reflect high adherence. Patients' adherence behavior is a multidimensional and dynamic process. The prolonged course of treatment, its cost, and unsatisfactory outcomes influenced the patients' adherence.
Assuntos
Fármacos Dermatológicos/uso terapêutico , Conhecimentos, Atitudes e Prática em Saúde , Adesão à Medicação , Percepção , Vitiligo/tratamento farmacológico , Adolescente , Adulto , Idoso , Distribuição de Qui-Quadrado , Estudos Transversais , Fármacos Dermatológicos/efeitos adversos , Fármacos Dermatológicos/economia , Custos de Medicamentos , Egito , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Medição de Risco , Fatores de Risco , Inquéritos e Questionários , Fatores de Tempo , Resultado do Tratamento , Vitiligo/diagnóstico , Vitiligo/economia , Vitiligo/psicologia , Adulto JovemRESUMO
Vitiligo is a common inflammatory skin disease with a worldwide prevalence of 0.5% to 2.0% of the population. In the pediatric population, the exact prevalence of vitiligo is unknown, although many studies state that most cases of vitiligo are acquired early in life. The disease is disfiguring, with a major psychological impact on children and their parents. Half of vitiligo cases have a childhood onset, needing thus a treatment approach that will minimize treatment side effects while avoiding psychological impacts. Management of vitiligo should take into account several factors, including extension, psychological impact, and possible associations with other autoimmune diseases. This review discusses the epidemiology of vitiligo and outlines the various clinical presentations associated with the disorder and their differential diagnosis. In addition, the pathophysiology and genetic determinants, the psychological impact of vitiligo, and management strategies are reviewed.
Assuntos
Vitiligo/diagnóstico , Vitiligo/terapia , Anti-Inflamatórios/uso terapêutico , Criança , Terapia Combinada , Fármacos Dermatológicos/uso terapêutico , Diagnóstico Diferencial , Suplementos Nutricionais , Predisposição Genética para Doença , Saúde Global , Humanos , Fototerapia , Psicoterapia , Transplante de Pele , Vitiligo/epidemiologia , Vitiligo/psicologiaRESUMO
BACKGROUND: The cosmetic problem that vitiligo produces affects patients psychologically. Many patients with vitiligo are suggested to cover their white skin patches with cosmetic products. There are formulations in traditional Iranian pharmacy to color these white skin patches. In this study, one of these formulations was compared with a cosmetic formulation. METHODS: Two groups of patients were selected. One group used a marketed formulation and other group used a traditional Iranian Pharmacy formulation. The quality of life of the patients was compared based on the Dermatology Life Quality Index Questionnaire. RESULTS: Both interventions were associated with statistically improved Dermatology Life Quality Index scores over the 8-week intervention (P < .05), although the difference between the 2 was not statistically significant (P = .436). CONCLUSION: Traditional Iranian Pharmacy formulation is effective in increasing the quality of life in vitiligo patients.
Assuntos
Cosméticos/administração & dosagem , Extratos Vegetais/administração & dosagem , Vitiligo/tratamento farmacológico , Adolescente , Adulto , Química Farmacêutica , Cosméticos/química , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Extratos Vegetais/química , Qualidade de Vida , Inquéritos e Questionários , Vitiligo/psicologia , Adulto JovemRESUMO
Vitiligo, an acquired pigmentary disorder of unknown origin, is the most frequent cause of depigmentation worldwide, with an estimated prevalence of 1%. The disorder can be psychologically devastating and stigmatising, especially in dark skinned individuals. Vitiligo is clinically characterised by the development of white macules due to the loss of functioning melanocytes in the skin or hair, or both. Two forms of the disease are well recognised: segmental and non-segmental vitiligo (the commonest form). To distinguish between these two forms is of prime importance because therapeutic options and prognosis are quite different. The importance of early treatment and understanding of the profound psychosocial effect of vitiligo will be emphasised throughout this Seminar.
Assuntos
Vitiligo/diagnóstico , Vitiligo/terapia , Fármacos Dermatológicos/uso terapêutico , Humanos , Transtornos Mentais/etiologia , Fototerapia/métodos , Vitiligo/epidemiologia , Vitiligo/imunologia , Vitiligo/psicologiaRESUMO
Vitiligo is a common depigmenting disease that can affect the skin and mucosal surfaces. Various treatments have been used over the years with varying repigmentation rates. This review looks at the evidence of commonly used therapies for vitiligo.
Assuntos
Fototerapia , Vitiligo/tratamento farmacológico , Corticosteroides/uso terapêutico , Antioxidantes/uso terapêutico , Inibidores de Calcineurina/uso terapêutico , Aconselhamento , Humanos , Imunossupressores/uso terapêutico , Melanócitos/transplante , Qualidade de Vida/psicologia , Preparações Clareadoras de Pele/uso terapêutico , Transplante de Pele , Vitiligo/psicologia , Vitiligo/terapiaRESUMO
BACKGROUND AND OBJECTIVES: Vitiligo is a difficult disease to treat. Recently, a 308-nm excimer laser has been shown to be effective in treating vitiligo. In addition, the patients with vitiligo have impairment in their quality of life. The aim of the study was to investigate the clinical efficacy, safety, and psychosocial impact after treating vitiligo with the 308-nm excimer laser. DESIGN AND SETTINGS: A prospective clinical trial conducted at dermatology clinics of hospitals affiliated with Qassim University, Saudi Arabia, from May 2012 to February 2013. PATIENTS AND METHODS: Forty-eight patients with 105 vitiliginous patches were treated using a 308-nm excimer laser. The treatment was performed twice per week for a maximum of 48 treatments or 100% repigmentation of lesions whichever was achieved first. The assessment of the clinical response and recording of side effects were performed biweekly. RESULTS: Out of 105 lesions in these patients, 63 lesions (60.0%) achieved over 75% repigmentation by laser treatment, 12 lesions (11.4%) showed 51% to 75% repigmentation, 9 lesions (8.6%) showed 26% to 50% repigmentation, and another 9 lesions (8.6%) showed 1% to 25% repigmentation, while 12 lesions (11.4%) showed no repigmentation. The average (+/-standard deviation [SD]) number of sessions needed to achieve repigmentation was 16.8 (8.0), whereas the average (+/-SD) number of sessions needed to realize Grade IV repigmentation was 20.2 (15). The type of repigmentation varied between lesions. Diffuse repigmentation was the most common pattern and occurred in 34 lesions (36.6%). Facial lesions responded better than lesions located elsewhere. Skin type did not play a statistically significant role (P=.07) in the lesions response to treatment. All side effects were mild and disappeared shortly after end of treatment sessions. CONCLUSION: The clinical data indicate that the treatment of vitiligo using the 308-nm excimer laser is effective and safe and improves psychosocial quality of life. Lesion location, duration of disease, and treatment duration are factors affecting the clinical and psychological outcome.
Assuntos
Lasers de Excimer/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Pigmentação da Pele/efeitos da radiação , Vitiligo/psicologia , Vitiligo/radioterapia , Adolescente , Adulto , Feminino , Humanos , Terapia com Luz de Baixa Intensidade/efeitos adversos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Qualidade de Vida , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Both Oral PUVA and PUVA sol have been successfully used in vitiligo treatment. However, there is paucity of studies comparing the two therapies, especially under subtropical conditions of abundant sunlight where PUVA sol is more feasible. OBJECTIVES: To compare the efficacy and side effects of oral PUVA versus oral PUVA sol therapy in generalized vitiligo. METHODS: Comparative prospective clinical trial conducted on consecutive patients of generalized vitiligo. Response to treatment was assessed using change in Lund & Browder (L & B) score for assessment of reduction in body surface area of involvement, patient global assessment (PGA) of improvement in vitiligo, investigator's global assessment (IGA) of extent of repigmentation, and quality of life (QOL) assessment using Tjioe et al questionnaire. RESULTS: Thirty five patients were recruited- 18 in PUVA and 17 in PUVA sol group. Mean percentage change in L & B score at 36 weeks was 46.4% in PUVA and 26.1% in PUVA sol group (P = 0.06), mean PGA score in PUVA was 4.58 ± 2.23 and in PUVA sol group was 6 ± 2.08 (P = 0.13), mean IGA score was 3.08 ± 1.68 in PUVA and 1.79 ± 0.57 in PUVA sol group (P = 0.11). QOL scores were significantly higher in PUVA group as compared to the PUVA sol group (P = 0.04). Side effects were comparable in two groups except for phototoxic side effects which were significantly more in PUVA group. CONCLUSIONS: PUVA is more efficacious than PUVA sol and also provides greater psychological benefit in treatment of generalized vitiligo but is associated with more phototoxic adverse effects.
Assuntos
Terapia PUVA , Vitiligo/tratamento farmacológico , Administração Oral , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Metoxaleno/uso terapêutico , Pessoa de Meia-Idade , Fármacos Fotossensibilizantes/uso terapêutico , Estudos Prospectivos , Qualidade de Vida , Resultado do Tratamento , Vitiligo/fisiopatologia , Vitiligo/psicologia , Adulto JovemRESUMO
Quality of life is defined by the World Health Organization as "individuals' perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns." Often overlooked in the past, it is nowadays considered, in a more holistic view of medicine, a decisive factor to understand the impact of diseases and improve the quality of medical care. Such evaluation is particularly relevant for dermatological diseases, because visibility of the lesions can significantly affect self-esteem and social relationships. Vitiligo represents an emblematic case: often disfiguring and located in visible areas, confused in the past (and, in many world regions, even in the present) with leprosy, often perceived by physicians as a harmless, purely cosmetic problem, it significantly decreases the quality of life of affected persons. After a brief overview on definition, usefulness and methods for the assessment of quality of life, the authors examine the peculiarities of its relationship with skin diseases, particularly vitiligo. The state of the art of knowledge and research in this field is presented, together with data showing usefulness and positive results of a multidisciplinary approach, which adequately keeps into account perceived quality of life, on patient's satisfaction, adherence to treatment protocols and, ultimately, better outcome of treatments. In this context, an important role can be played by support communities, groups of patients and dedicated associations and societies, connected through modern communication networks like the Internet.
Assuntos
Qualidade de Vida , Vitiligo/psicologia , Feminino , Humanos , Internet , Masculino , Autoimagem , Grupos de Autoajuda/organização & administração , Meio Social , Inquéritos e Questionários , Vitiligo/complicações , Organização Mundial da SaúdeRESUMO
This paper reviews the effectiveness of therapeutic interventions on quality of life for adult patients with vitiligo. We systematically searched nine databases from 1990 to February 2010 and reviewed randomized controlled trials and quasi-experimental studies of current therapeutic interventions for vitiligo, including oral, topical, combination, camouflage, cognitive-behavioural therapy and grafting. Quality of life outcomes were collected. The Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument was used for quality assessment. Nine studies were included for this review, and all treatments were found to improve quality of life for vitiligo patients. Disease-altering interventions were effective in improving quality of life. Lifestyle-altering interventions were found to be selectively effective for patients with more severe quality of life impairment. Current interventions for vitiligo are effective in improving quality of life either by enhancing physical appearance of the patient or by addressing the psychological distress directly. Less effectiveness was achieved for the functional and social dimensions, which are more dependent on social and cultural norms. This suggests that current interventions alone are inadequate to address the holistic quality of life challenges associated with vitiligo.